Environmental basis of primary biliary cholangitis
- PMID: 29307284
- PMCID: PMC5788149
- DOI: 10.1177/1535370217748893
Environmental basis of primary biliary cholangitis
Abstract
Autoimmunity is a consequence of both genetic and environmental factors, occurring in genetically susceptible hosts with environmental triggers. While genome-wide association studies have revealed a number of susceptible genes contributing to etiology, the environmental triggers remain poorly understood. Primary biliary cholangitis, formally known as primary biliary cirrhosis, is considered a model autoimmune disease for which our group has extensively evaluated environmental factors involved in its etiology. Bacterial infection and xenobiotics have been proposed as candidate environmental factors that may explain tolerance breakdown and production of primary biliary cholangitis-specific antimitochondrial autoantibodies. Large-scale case-control studies have consistently detected an association of primary biliary cholangitis with urinary tract infections caused by Escherichia coli, as E. coli PDC-E2 is molecularly similar to human PDC-E2, the immunodominant target of AMAs. Another bacterium of interest is Novosphingobium aromaticivorans, a ubiquitous xenobiotic-metabolizing bacterium that produces lipoylated proteins, which are highly reactive with sera from primary biliary cholangitis patients. Regarding xenobiotics, case-control studies have suggested that frequent use of nail polish is associated with an increased susceptibility to primary biliary cholangitis. We found that 2-octynamide, the conjugate derived from 2-octynoic acid present in cosmetics, lipsticks, and some chewing gums, was unique in both its quantitative structure-activity relationship analysis and reactivity with primary biliary cholangitis sera. 2-nonyamide is another xenobiotic that also has the optimal chemical structure for xenobiotic modification of the PDC-E2 epitope, as demonstrated by the enhanced epitope recognition with AMA-positive PBC sera. Moreover, we found that C57BL/6 mice immunized with 2-octynoic acid-BSA possess many of the features characteristic to primary biliary cholangitis. Impact statement Autoimmunity is believed to develop in genetically susceptible hosts with triggers from the environment. Researchers have recently demonstrated that bacteria and xenobiotics commonly present in our environment are potential triggers of tolerance breakdown against autoantigens and autoimmunity, particularly in primary biliary cholangitis (PBC). The link between xenobiotics and PBC has been further confirmed with the establishment of PBC model mice by immunizing mice with xenobiotics.
Keywords: Environment; animal models; anti-mitochondrial autoantibodies; autoimmune; genetic background; primary biliary cholangitis.
Figures


Similar articles
-
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid.J Immunol. 2005 May 1;174(9):5874-83. doi: 10.4049/jimmunol.174.9.5874. J Immunol. 2005. PMID: 15845458
-
Xenobiotics and loss of tolerance in primary biliary cholangitis.World J Gastroenterol. 2016 Jan 7;22(1):338-48. doi: 10.3748/wjg.v22.i1.338. World J Gastroenterol. 2016. PMID: 26755880 Free PMC article. Review.
-
Pathogen infections and primary biliary cholangitis.Clin Exp Immunol. 2019 Jan;195(1):25-34. doi: 10.1111/cei.13198. Epub 2018 Sep 17. Clin Exp Immunol. 2019. PMID: 30099750 Free PMC article. Review.
-
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium.Hepatology. 2003 Nov;38(5):1250-7. doi: 10.1053/jhep.2003.50446. Hepatology. 2003. PMID: 14578864
-
Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization.J Immunol. 2007 Aug 15;179(4):2651-7. doi: 10.4049/jimmunol.179.4.2651. J Immunol. 2007. PMID: 17675529
Cited by
-
Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?Front Immunol. 2023 May 30;14:1184252. doi: 10.3389/fimmu.2023.1184252. eCollection 2023. Front Immunol. 2023. PMID: 37325634 Free PMC article. Review.
-
Antibodies directed against bacterial antigens in sera of Polish patients with primary biliary cholangitis.Front Cell Infect Microbiol. 2025 Jan 7;14:1410282. doi: 10.3389/fcimb.2024.1410282. eCollection 2024. Front Cell Infect Microbiol. 2025. PMID: 39844835 Free PMC article.
-
The role of soluble adenylyl cyclase in sensing and regulating intracellular pH.Pflugers Arch. 2024 Apr;476(4):457-465. doi: 10.1007/s00424-024-02952-x. Epub 2024 Apr 6. Pflugers Arch. 2024. PMID: 38581526 Free PMC article. Review.
-
Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale.Liver Int. 2024 Oct;44(10):2834-2846. doi: 10.1111/liv.16060. Epub 2024 Aug 5. Liver Int. 2024. PMID: 39101371
-
The Role of Epigenetics in Primary Biliary Cholangitis.Int J Mol Sci. 2022 Apr 28;23(9):4873. doi: 10.3390/ijms23094873. Int J Mol Sci. 2022. PMID: 35563266 Free PMC article. Review.
References
-
- Doherty DG. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J Autoimmun 2016; 66:60–75 - PubMed
-
- Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME. Definition of human autoimmunity–autoantibodies versus autoimmune disease. Autoimmun Rev 2010; 9:A259–66 - PubMed
-
- Gianchecchi E, Fierabracci A. Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of toll-like receptors. Autoimmun Rev 2015; 14:971–83 - PubMed
-
- Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun 2016; 66:25–39 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources